From Bioblast
Revision as of 15:10, 19 December 2022 by Beno Marija (talk | contribs) (Created page with "{{O2k-Network Lab |institution=Toronto General Hospital & University Health Network, CA |address=200 Elizabeth St |area code=M5G 2C4 |city=Toronto |state=Ontario (ON) |country...")
CA Toronto Bellissimo C
| O2k-Network Lab | Toronto General Hospital & University Health Network, CA |
|---|---|
| Address | 200 Elizabeth St, M5G 2C4 |
| City | Toronto |
| State/Prov | Ontario (ON) |
| Country | Canada |
| Weblink | |
| Contact | Bellissimo Catherine |
| Team | |
| Team previous | |
| Status | O2k 2023- |
| Oroboros Events | |
| Topics |
O2k-Publications
| Published | Reference | |
|---|---|---|
| Bellissimo 2023 Exp Physiol | 2023 | Bellissimo CA, Castellani LN, Finch MS, Murugathasan M, Gandhi S, Sweeney G, Abdul-Sater AA, MacPherson REK, Perry CGR (2023) Memory impairment in the D2.mdx mouse model of Duchenne muscular dystrophy is prevented by the adiponectin receptor agonist ALY688. https://doi.org/10.1113/ep091274 |
O2k-Abstracts
update please
